发明名称 IMMUNE RESPONSE ACCOMMODATIVE COMPOSITION
摘要 PURPOSE: To provide an immune response-regulating composition that is used for inhibition of rejection symptoms to transplanted tissue and for inhibiting the host disease from attacking to the transplanted tissue. CONSTITUTION: This immune response-regulating composition includes IL-4 receptor and CTLA4 receptor. As an IL-4 receptor, are cited a monoclonal antibody that specifically recognizes and links to IL-4, namely soluble IL-4 receptor. In addition, the CTLA4 receptor is, for example, CTLA4 Ig fused protein, CD28 Ig/CTLA4 Ig fused protein hybrid. The CTLA4 Ig fused protein bears the first amino acid sequence containing an amino acid residues from 1-125 amino acids corresponding to the extracellular domain in the CTLA4 and the second amino acid sequence containing the amino acid sequence corresponding to the human immunoglobulin Cr1 hinge, CH2 and CH3 regions.
申请公布号 JPH0769914(A) 申请公布日期 1995.03.14
申请号 JP19940023365 申请日期 1994.01.24
申请人 BRISTOL MYERS SQUIBB CO 发明人 PIITAA ESU RINSURII;JIEFURII EE RIDOBETAA;NAITEIN KEE DEIMURU;UIRIAMU BUREDEI;FUIRITSUPU EMU UOOREESU
分类号 A61K38/00;A61K38/17;A61K39/00;A61K39/395;A61K45/00;A61P29/00;A61P31/12;A61P31/14;A61P31/18;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P37/08;C07K;C07K14/00;C07K14/705;C07K14/715;C07K14/725;C07K16/00;C07K16/28;C07K16/42;C07K19/00;C12N5/06;C12N5/10;C12N15/02;C12N15/09;C12N15/12;C12N15/13;C12P21/02;C12P21/08;C12R1/91;G01N33/53;G01N33/564;G01N33/566;G01N33/577 主分类号 A61K38/00
代理机构 代理人
主权项
地址